Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004287762 | SCV003937397 | uncertain significance | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | The c.403C>T (p.H135Y) alteration is located in exon 2 (coding exon 1) of the B3GALT2 gene. This alteration results from a C to T substitution at nucleotide position 403, causing the histidine (H) at amino acid position 135 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |